Deciphera Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q1 2024.
  • Deciphera Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $3.76M, a 3.18% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $16.6M, a 103% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $16.4M, a 264% increase from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $4.51M, a 3894% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $113K, a 97.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $16.6M $3.76M +$116K +3.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $16.4M $4.48M +$2.53M +130% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $13.9M $4.11M +$2.27M +123% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-30
Q2 2023 $11.6M $4.21M +$3.49M +480% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $8.16M $3.65M +$3.65M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $4.51M $1.95M +$1.94M +32367% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $2.57M $1.84M +$2.01M Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-30
Q2 2022 $563K $727K +$646K +798% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$83K $0 -$196K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $113K $6K -$253K -97.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $366K -$170K -$466K -157% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $832K $81K -$1.61M -95.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.44M $196K -$2.26M -92% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $4.7M $259K -$2.9M -91.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-07
Q3 2020 $7.6M $296K -$1.86M -86.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $9.46M $1.69M +$176K +11.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $9.28M $2.46M +$814K +49.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $8.47M $3.16M +$1.63M +106% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-08
Q3 2019 $6.84M $2.16M +$703K +48.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.14M $1.52M +$776K +105% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $5.37M $1.64M +$1.12M +215% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $4.25M $1.53M +$1.11M +259% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $3.14M $1.45M +$1.31M +917% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $1.83M $739K +$674K +1037% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $1.16M $521K +$504K +2965% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $651K $426K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-09
Q3 2017 $143K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $65K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $17K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.